Da Volterra SAS - Company Review
Da Volterra SAS - Company ReviewSummary
Da Volterra SAS (Volterra) is a biotechnology company that develops and commercializes healthcare solutions to treat life-threatening bacterial infections and antibiotic resistance at the root level. The company develops medical device for preventing clostridium difficile infections. It also develops products for preventing dissemination of resistant bacteria during antibiotic treatment in animals. Volterra offers drug delivery, microbiology, clinical and preclinical development of antibacterials and antibiotic resistance services. The company partners with other pharma and biotech companies to develop its products. Da Volterra is headquartered in Paris, France.
This comprehensive company report of Da Volterra SAS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.